Please assess the completion status of the following clinical trial:

Trial Title: Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: FAMILY_BASED
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Individuals thought to have schizophrenia or schizoaffective disorder, be the parent of such an individual, or be in the matched control group of unrelated individuals not thought to have schizophrenia or schizoaffective disorder~Exclusion Criteria:~* Unable to give informed consent;~* Psychotic disorder judged to be secondary to substance abuse, psychotic disorder that appears to be secondary to a known medical or neurological disorder, or severe mental retardation

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 79 Years
- Healthy Volunteers: t

Study Arms:
- Diagnostic (Type: None): A diagnostic was performed

Based on this trial design, predict the completion outcome and termination type (if applicable).